Sensus Healthcare Q1 2024 GAAP EPS $0.14 Beats $(0.06) Estimate, Sales $10.663M Beat $4.120M Estimate
Portfolio Pulse from Benzinga Newsdesk
Sensus Healthcare (NASDAQ:SRTS) reported Q1 2024 earnings of $0.14 per share, surpassing the $(0.06) estimate, marking a 333.33% beat and a 216.67% increase from last year's $(0.12) per share loss. Sales reached $10.663M, exceeding the $4.120M estimate by 158.81% and showing a 212.33% increase from last year's $3.414M.

May 09, 2024 | 9:33 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Sensus Healthcare reported a significant beat on both EPS and sales for Q1 2024, with EPS at $0.14 against a $(0.06) estimate and sales of $10.663M against a $4.120M estimate.
The substantial beat on both earnings per share and sales estimates for Sensus Healthcare indicates strong financial health and operational efficiency. This performance, especially when it significantly surpasses analyst expectations, is likely to instill investor confidence and could lead to a positive short-term impact on the stock price. The comparison to the previous year's losses highlights remarkable growth and turnaround, further underpinning the positive outlook.
CONFIDENCE 90
IMPORTANCE 95
RELEVANCE 100